PembROlizumab With or Without Microbial EcOsystem ThErapeutic 4 (MET4) in Advanced Head and Neck Squamous Cell Carcinoma
Clinical trial NCT05743777 · WITHDRAWN
Trial details
- NCT number
- NCT05743777
- Sponsor
- Canadian Cancer Trials Group
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-12
- Primary completion
- 2023-05-12
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.